Vernieri C, Corti F, Nichetti F, Ligorio F, et al. Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative
breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with
different clinical implications. Breast Cancer Res 2020;22:33.
PMID: 32252811